NR3C2 and hydrops fetalis: Administration of optimal medical treatments for patients with HF, including medications such as beta-adrenergic receptor blockers,[8] angiotensin converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs),[9] and aldosterone receptor antagonists,[10] have been proven to be associated with significantly improved prognosis in patients with HF.